imipenem, anhydrous has been researched along with Lupus Erythematosus, Systemic in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Afifi, A; De Lord, D; Rasool, S | 1 |
Chaudhry, ZA; Ginzler, E; Sharif, S; Terebelo, S | 1 |
Duan, M; Jie, L; Shi, W; Sun, W | 1 |
Dendumrongsup, T; Dissaneewate, P; Kritsaneepaiboon, S; Limwattana, S; Vachvanichsanong, P | 1 |
Hara, H; Ochiai, T; Wakui, F | 1 |
Mine, S; Nakazaki, M; Ozaki, H; Saeki, N; Yamakami, I; Yamaura, A; Yoneyama, T | 1 |
Becq-Giraudon, B; Breton, I; Burucoa, C; Fauchère, JL; Ramassamy, A; Soyer, J | 1 |
Coppini, M; Ferdani, G; Folgaresi, M; Pincelli, C | 1 |
1 review(s) available for imipenem, anhydrous and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Systemic lupus erythematosus-related pancreatitis in children.
Topics: Abdominal Pain; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Child; Female; Humans; Imipenem; Lupus Erythematosus, Systemic; Pancreatitis; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
7 other study(ies) available for imipenem, anhydrous and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Case of atypical cutaneous
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tobramycin; Treatment Outcome | 2019 |
Disseminated nocardiosis in an immunosuppressed patient with systemic lupus erythematosus and neuromyelitis optica spectrum disorder.
Topics: Brain Abscess; Female; Humans; Imipenem; Immunocompromised Host; Lung Abscess; Lupus Erythematosus, Systemic; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Nocardia Infections; Plasmapheresis; Prednisone; Radiography, Thoracic; Sulfamethoxazole; Tomography, X-Ray Computed; Trimethoprim | 2021 |
A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Blood Cell Count; Bone Marrow Examination; Cilastatin; Female; Humans; Hydroxychloroquine; Imipenem; Lung; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Pneumonia; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Disseminated Nocardia farcinica infection in a patient with systemic lupus erythematosus.
Topics: Anti-Bacterial Agents; Debridement; Drainage; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Nocardia; Nocardia Infections; Prednisolone; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
[Nocardial brain abscess: surgery and postoperative antibiotic therapy].
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; beta-Alanine; Brain Abscess; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Lupus Erythematosus, Systemic; Male; Middle Aged; Minocycline; Nocardia Infections; Postoperative Care; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Western blot monitoring of disseminated Nocardia nova infection treated with clarithromycin, imipenem, and surgical drainage.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Blotting, Western; Clarithromycin; Drug Therapy, Combination; Glucocorticoids; Humans; Imipenem; Immunocompromised Host; Lupus Erythematosus, Systemic; Male; Middle Aged; Nocardia; Nocardia Infections; Prednisone; Thienamycins | 1996 |
Primary cutaneous nocardiosis.
Topics: Adult; Female; Follow-Up Studies; Humans; Imipenem; Lupus Erythematosus, Systemic; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Skin Diseases, Bacterial; Thienamycins; Treatment Outcome | 1998 |